Recent Finacing
Recent Raise
HaemaLogiX develops monoclonal antibody immunotherapies for multiple myeloma and other blood cancers, advancing KappaMab manufacturing and clinical development with planned higher-dose and lambda-directed studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Haemalogix.
